HMN 2025: How NRTI use is linked to threat for main open-angle glaucoma

Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is related to an elevated threat for main open-angle glaucoma (POAG), based on a research published on-line June 20 in Ophthalmology.

Kenneth Pham, from the University of Pennsylvania in Philadelphia, and colleagues performed a retrospective cohort study involving 305,441 adults aged 40 years or older with linked digital well being report information from the National Institutes of Health All of Us dataset to evaluate the affiliation of NRTI use with POAG. A cohort of 1:10 NRTI customers to nonusers was created utilizing a propensity score-matching design; 718 people with NRTI use have been recognized and matched with 7,180 nonusers.

The researchers discovered that the speed of POAG was 4.32% in NRTI customers and a pair of.00% within the propensity score-matched {control} group. POAG threat was elevated in affiliation with NRTI use (odds ratio, 2.21). NRTI use remained considerably related to an elevated threat of creating POAG after adjustment for residual imbalance of household historical past of POAG, HIV analysis, and hepatitis B analysis (odds ratio, 1.84). NRTIs remained considerably related to POAG threat after matching and adjusting for self-reported eye physician visits (odds ratio, 2.30).

“A chance that might clarify the affiliation between NRTI use and POAG threat is that elevated medical surveillance related to NRTI use might enable better alternative for POAG analysis, although we’ve got carried out a number of analyses to detect such a mechanism,” the authors write.

“Moreover, analyses for cataracts and angle-closure glaucoma didn’t reveal an affiliation between NRTI use and people different eye circumstances. Together, these outcomes don’t discover proof that larger POAG charges noticed amongst NRTI customers can merely be attributed to extra examination of the eyes.”

2025 HealthDay.